BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23087138)

  • 1. Decreased analgesic effect of morphine, but not buprenorphine, in patients with advanced P-glycoprotein(+) cancers.
    Wang J; Cai B; Huang DX; Yang SD; Guo L
    Pharmacol Rep; 2012; 64(4):870-7. PubMed ID: 23087138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of intestinal P-glycoprotein increases the analgesic effects of oral morphine in a streptozotocin-induced diabetic mouse model.
    Nawa A; Fujita-Hamabe W; Kishioka S; Tokuyama S
    Drug Metab Pharmacokinet; 2011; 26(6):584-91. PubMed ID: 21878740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative relationship between morphine analgesia and P-glycoprotein expression levels in the brain.
    Hamabe W; Maeda T; Kiguchi N; Yamamoto C; Tokuyama S; Kishioka S
    J Pharmacol Sci; 2007 Dec; 105(4):353-60. PubMed ID: 18071274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can P-glycoprotein expression on malignant tumor tissues predict opioid transport at the blood-brain barrier in cancer patients?
    Mégarbane B; Alhaddad H
    Pharmacol Rep; 2013; 65(1):235-6. PubMed ID: 23563044
    [No Abstract]   [Full Text] [Related]  

  • 5. P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac.
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Zhang Y; Laracuente ML; DeMarco KM; Ronaldson PT; Davis TP
    PLoS One; 2014; 9(2):e88516. PubMed ID: 24520393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier.
    Suzuki T; Zaima C; Moriki Y; Fukami T; Tomono K
    J Drug Target; 2007 Jan; 15(1):67-74. PubMed ID: 17365275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels.
    Schaefer CP; Arkwright NB; Jacobs LM; Jarvis CK; Hunn KC; Largent-Milnes TM; Tome ME; Davis TP
    PLoS One; 2018; 13(2):e0192340. PubMed ID: 29414996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
    Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
    Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Altered intestinal P-glycoprotein expression levels affect pharmacodynamics under diabetic condition].
    Nawa A; Fujita-Hamabe W; Kisioka S; Tokuyama S
    Yakugaku Zasshi; 2012; 132(2):161-6. PubMed ID: 22293693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal buprenorphine combined with spinal morphine and naropine for pain relief in chronic peripheral vasculopathy.
    Aurilio B; Pace MC; Passavanti MB
    Minerva Anestesiol; 2005; 71(7-8):445-9. PubMed ID: 16012418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism.
    Slosky LM; Thompson BJ; Sanchez-Covarrubias L; Zhang Y; Laracuente ML; Vanderah TW; Ronaldson PT; Davis TP
    Mol Pharmacol; 2013 Nov; 84(5):774-86. PubMed ID: 24019224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravenous patient-controlled analgesia with buprenorphine versus morphine after lumbar spinal fusion--a prospective randomized clinical trial.
    Chang KY; Chang WK; Chang WL; Lin SM; Chan KH; Sung CS; Tsou MY
    Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):153-9. PubMed ID: 17037003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
    Quigley C; Joel S; Patel N; Baksh A; Slevin M
    Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual buprenorphine compared to morphine delivered by a patient-controlled analgesia system as postoperative analgesia after prostatectomy.
    Gaitini L; Moskovitz B; Katz E; Vaisberg A; Vaida S; Nativ O
    Urol Int; 1996; 57(4):227-9. PubMed ID: 8961492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of postoperative pain with intravenous PCA system. Comparison with morphine, metamizole, and buprenorphine].
    Torres LM; Collado F; Almarcha JM; Huertas VG; de Antonio P; Rodríguez M
    Rev Esp Anestesiol Reanim; 1993; 40(4):181-4. PubMed ID: 8372257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine vs. morphine via the epidural route: a controlled comparative clinical study of respiratory effects and analgesic activity.
    Pasqualucci V; Tantucci C; Paoletti F; Dottorini ML; Bifarini G; Belfior R; Berioli MB; Grassi V; Sorbini CA
    Pain; 1987 Jun; 29(3):273-286. PubMed ID: 3614964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine versus morphine for patient-controlled analgesia after cholecystectomy.
    Dingus DJ; Sherman JC; Rogers DA; DiPiro JT; May R; Bowden TA
    Surg Gynecol Obstet; 1993 Jul; 177(1):1-6. PubMed ID: 8322143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats.
    Bulka A; Kouya PF; Böttiger Y; Svensson JO; Xu XJ; Wiesenfeld-Hallin Z
    Eur J Pharmacol; 2004 May; 492(1):27-34. PubMed ID: 15145702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice.
    Gades NM; Danneman PJ; Wixson SK; Tolley EA
    Contemp Top Lab Anim Sci; 2000 Mar; 39(2):8-13. PubMed ID: 11487232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.